Go to main content


Remarkable family
Support for
Remarkable growth

Developing cell immunotherapy
based on NK cells and stem
cell-based treatments for rare diseases

  • Established inJuly 2011.
  • Address131-1 Ihyeon-ro 30-beongil, Giheung-gu, Yongin, Gyeonggi-do
    (319 Bojeong-dong, Giheung-gu, Yongin-si, Gyeonggi-do)
  • ContactTel. +82-31-260-9600 / Fax: +82-31-260-9232

  • GC LabCell, which came out of a merger between the cell therapy division of GC and the cord blood storage division of GCLabs, focuses on its strategic tasks of researching and developing natural killer (NK) cell-based immunotherapy agents and stem cell-based treatments for rare diseases.
  • The company plans to expand its business into development of more diverse stem cell-based treatments and a comprehensive range of healthcare services for the global market.

View website


GC녹십자는 이메일 수집을 거부합니다

본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나
그 밖의 기술적 장치를 이용하여 무단으로 이메일 주소를 수집하는 행위를 거부하며,
이를 위반시 정보통신망 이용촉진 및 정보보호 등에 관한 법률에 의해 형사처벌됨을
유념하시기 바랍니다

게시일: 2003년 9월 1일